31 results on '"Zimran, Eran"'
Search Results
2. Dysregulated iron metabolism in polycythemia vera: etiology and consequences.
3. Re-induction versus salvage for D14-resiudal acute myeloid leukemia: A retrospective multi-center study
4. Ex vivo expansion of hematopoietic stem cells: Finally transitioning from the lab to the clinic
5. Long-Term Results with Thiotepa-Containing Conditioning Regimens for Autologous Stem Cell Transplantation
6. High rate of adenovirus detection in gastrointestinal biopsies of symptomatic stem cell transplant recipients.
7. Novel strategies for the treatment of myelofibrosis driven by recent advances in understanding the role of the microenvironment in its etiology [version 1; peer review: 3 approved]
8. Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?
9. Risk factors and outcomes of COVID‐19 in adult patients with hematological malignancies: A single‐center study showing lower than expected rates of hospitalization and mortality.
10. Mesenchymal stroma/stem cells: Haematologists' friend or foe?
11. Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma.
12. Paradoxical response in ocular bartonellosis
13. P-026 Safety and efficacy of a locally produced novel anti-BCMA chimeric antigen receptor T-cell (CART) (HBI0101) for the treatment of relapsed and refractory multiple myeloma
14. OA-34 Feasibility of a novel academic anti-BCMA chimeric antigen receptor T-cell (CART) (HBI0101) for the treatment of relapsed and refractory AL amyloidosis
15. Neutrophil decline rate following autologous transplant for lymphoma is a predictor of patients' outcome.
16. COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome.
17. ATG-F Versus ATG-T for Graft Versus Host Disease Prevention in Allogeneic Stem Cell Transplantation: A Retrospective Comparative Study
18. Letermovir Prophylaxis for High-Risk Allogenic Transplantation Recipients, Real- World Israeli Experience
19. Tecam (Thiotepa, Etoposide, cyclophosphamide, Cytarabine and Melphalan) Is an Effective and Safe Conditioning Regimen for Autologous Transplant in Lymphoma
20. COVID-19 Among Patients with Hematological Malignancies: Experience from a Tertiary Center Showing Lower Than Expected Mortality and Establishing the Safety of in-Hospital Patient Care during the Pandemic
21. Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor.
22. Bilateral Adrenal Hemorrhage in a Patient with Antiphospholipid Syndrome Following Reversal of Warfarin-induced Over-anticoagulation.
23. Novel treatments to tackle myelofibrosis.
24. Current approaches to challenging scenarios in myeloproliferative neoplasms.
25. The Exhaustion of Adult Hematopoietic Stem Cells in Ex Vivo Cultures Can Be Overcome by a Histone Deacetylase Inhibitor
26. A Simplified Scoring Tool for Prediction of Readmission in Elderly Patients Hospitalized in Internal Medicine Departments.
27. Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation
28. Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial.
29. Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis.
30. Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation.
31. Genomic characterization of spleens in patients with myelofibrosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.